Charles York II
2021
In 2021, Charles York II earned a total compensation of $7.9M as Chief Operating Officer and Chief Financial Officer at Day One Biopharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $218,300 |
| Option Awards | $4,670,232 |
| Salary | $396,042 |
| Stock Awards | $2,534,266 |
| Total | $7,918,839 |
York received $4.7M in option awards, accounting for 59% of the total pay in 2021.
York also received $100K in bonus, $218.3K in non-equity incentive plan, $396K in salary and $2.5M in stock awards.
Rankings
In 2021, Charles York II's compensation ranked 1,466th out of 12,415 executives tracked by ExecPay. In other words, York earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,466 out of 12,415 | 88th |
Division Manufacturing | 529 out of 5,505 | 90th |
Major group Chemicals And Allied Products | 199 out of 2,375 | 92nd |
Industry group Drugs | 165 out of 2,096 | 92nd |
Industry Pharmaceutical Preparations | 112 out of 1,546 | 93rd |
Source: SEC filing on April 28, 2022.
York's colleagues
We found two more compensation records of executives who worked with Charles York II at Day One Biopharmaceuticals in 2021.